drugset
drugset / Trial / NCT02386488

Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women

NCT02386488 ↗

Phase 1 Completed 64 enrolled H. Lundbeck A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the pharmacokinetic (PK) parameters of vortioxetine after single and multiple oral dosing to healthy Chinese men and women.

Timeline

Start
2015-03
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 10 mg Oral
Subject Vortioxetine Unknown 20 mg Oral

Indications

No indication recorded.